Head to head
Cardinal Health vs McKesson
Side-by-side on the measures that matter, with a plain-English read. Full detail: CAH · MCK
CAH
Cardinal Health
232.16-0.55%
1-year price shape — +50% over the period
Quant Rating B · 83/100
vs
MCK
McKesson
910.33-1.23%
1-year price shape — +22% over the period
Quant Rating C · 65/100
1-year performance, rebased to 100
McKesson edges it on the scoreable measures. McKesson trades cheapest on trailing earnings; McKesson earns the most per share.
| CAH | MCK | |
|---|---|---|
| Snapshot | ||
| Sector | Medical Distribution | Medical Distribution |
| Last price | 232.16 | 910.33 |
| Change today | -0.55% | -1.23% |
| 1-year return | +49.6% | +21.8% |
| Market cap | $53.76B | $106.14B |
| 52-week range | 150.45 – 257.70 | 722.11 – 996.84 |
| Valuation | ||
| P/E (TTM) | 32.11 | 24.31 |
| P/E percentile, own 5-yr range | 56th | 45th |
| P/B | -18.65 | -25.03 |
| Dividend yield | 0.88% | 0.36% |
| Profitability & growth | ||
| EPS (TTM) | 7.23 | 38.55 |
| Net profit (TTM) | $1.67B | $4.49B |
| Revenue (TTM) | $254.25B | $410.98B |
| Revenue growth (YoY) | +5.8% | +7.7% |
| Gross margin | 3.8% | 3.6% |
| Operating margin | 1.2% | 1.7% |
| Net margin | 0.7% | 1.1% |
| Free cash flow (TTM) | $4.53B | $6.15B |
| Ownership & sentiment | ||
| Institutional ownership | 91.0% | 92.0% |
| Insider activity (12mo) | 26 buy / 24 sell | 23 buy / 25 sell |
| Short interest (% of float) | 2.9% | 2.5% |
| Analyst consensus | 86% buy / 14% hold (14) | 83% buy / 17% hold (12) |
| Analyst price target | $270 (+16%) | $1,001 (+10%) |
| StockVane view | ||
| StockVane Quant Rating | B (83) | C (65) |
| Company | ||
| Employees | 63,900 | 43,000 |
| Founded | 1979 | 1833 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.